UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study

Journal of rheumatology, 2014-08, Vol.41 (8), p.1703-1711

2014

Volltextzugriff (PDF)

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

Clinical therapeutics, 2012-10, Vol.34 (10), p.2091-2103

2012

Volltextzugriff (PDF)

Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

Arthritis & rheumatology (Hoboken, N.J.), 2012-03, Vol.64 (3), p.876-884

2012

Volltextzugriff (PDF)

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

The New England journal of medicine, 2014-07, Vol.371 (2), p.130-139

2014

Volltextzugriff (PDF)

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study

Arthritis & rheumatology (Hoboken, N.J.), 2015-06, Vol.67 (6), p.1424-1437

2015

Volltextzugriff (PDF)

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator

Arthritis research & therapy, 2013-02, Vol.15 (1), p.R25-R25

2013

Volltextzugriff (PDF)

Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study

Arthritis care & research (2010), 2012-10, Vol.64 (10), p.1462-1470

2012

Volltextzugriff (PDF)

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

Rheumatology (Oxford, England), 2013-07, Vol.52 (7), p.1285-1292

2013

Volltextzugriff (PDF)

Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli

Diabetes (New York, N.Y.), 1995-04, Vol.44 (4), p.441-445

1995

Volltextzugriff (PDF)

Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression

Diabetes (New York, N.Y.), 1994-10, Vol.43 (10), p.1185-1189

1994

Volltextzugriff (PDF)

Dexamethasone inhibits insulin-stimulated recruitment of GLUt4 to the cell surface in rat skeletal muscle

Metabolism, clinical and experimental, 1998, Vol.47 (1), p.3-6

1998

Volltextzugriff (PDF)

Classification of clinical attributes in tooth appearance

Practical procedures & aesthetic dentistry, 2008-04, Vol.20 (3), p.143

Weinstein, Steven P

2008

Volltextzugriff (PDF)

Efficacy and safety of rilonacept (interleukin‐1 trap) in patients with cryopyrin‐associated periodic syndromes: Results from two sequential placebo‐controlled studies

Arthritis and rheumatism, 2008-08, Vol.58 (8), p.2443-2452

2008

Volltextzugriff (PDF)

A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndrome

Arthritis and rheumatism, 2008-08, Vol.58 (8), p.2432-2442

2008

Volltextzugriff (PDF)

Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone

Diabetes (New York, N.Y.), 1992-06, Vol.41 (6), p.728-735

1992

Volltextzugriff (PDF)

Sustainability Science: The Emerging Paradigm and the Urban Environment

1. Aufl., 2012

Volltextzugriff (PDF)

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

Journal of human hypertension, 2002-01, Vol.16 (1), p.5-11

2002

Volltextzugriff (PDF)

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

Journal of human hypertension, 2002-01, Vol.16 (1), p.5

2002

Volltextzugriff (PDF)

Stimulation of glucose transport by thyroid hormone in ARL 15 cells : increased abundance of glucose transporter protein and messenger ribonucleic acid

Endocrinology (Philadelphia), 1990-03, Vol.126 (3), p.1421-1429

1990

Volltextzugriff (PDF)

Tissue distribution of the human GLUT3 glucose transporter

Endocrinology (Philadelphia), 1993-06, Vol.132 (6), p.2538-2543

1993

Volltextzugriff (PDF)

Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone : evidence for hormonal regulation of the hepatic glucose transport system

Endocrinology (Philadelphia), 1994-08, Vol.135 (2), p.649-654

1994

Volltextzugriff (PDF)

Tobacco Smoking: Current Concepts in Etiology and Treatment

Psychiatry (Washington, D.C.), 2003-09, Vol.66 (3), p.183-199

2003

Volltextzugriff (PDF)

Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle

Endocrinology (Philadelphia), 1991-07, Vol.129 (1), p.455-464

1991

Volltextzugriff (PDF)

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

Metabolism, clinical and experimental, 1993-10, Vol.42 (10), p.1365-1369

1993

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(211)

Publikationsform

Sprache

Englisch
(249)

Erscheinungsjahr

n.n

Thema

Science & Technology
(180)
Life Sciences & Biomedicine
(162)
Humans
(128)
Male
(91)
Female
(79)
Biological And Medical Sciences
(77)
Middle Aged
(65)
Adult
(57)
Medical Sciences
(55)
Aged
(47)
Animals
(43)
Treatment Outcome
(37)
Double-Blind Method
(36)
Adolescent
(24)
Fundamental And Applied Biological Sciences. Psychology
(24)
Neurosciences & Neurology
(21)
Rats
(20)
Aged, 80 And Over
(19)
Risk Factors
(18)
Child
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Rilonacept for gout flare prevention in patients receiving uric acid-lowering therapy: results of RESURGE, a phase III, international safety study

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study

Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator

Rilonacept (interleukin‐1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double‐blind, placebo‐controlled, confirmatory efficacy study

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

Glucocorticoid-induced insulin resistance: dexamethasone inhibits the activation of glucose transport in rat skeletal muscle by both insulin- and non-insulin-related stimuli

Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression

Dexamethasone inhibits insulin-stimulated recruitment of GLUt4 to the cell surface in rat skeletal muscle

Classification of clinical attributes in tooth appearance

Efficacy and safety of rilonacept (interleukin‐1 trap) in patients with cryopyrin‐associated periodic syndromes: Results from two sequential placebo‐controlled studies

A pilot study to evaluate the safety and efficacy of the long‐acting interleukin‐1 inhibitor rilonacept (interleukin‐1 trap) in patients with familial cold autoinflammatory syndrome

Role of glucose transporters in glucocorticoid-induced insulin resistance. GLUT4 isoform in rat skeletal muscle is not decreased by dexamethasone

Sustainability Science: The Emerging Paradigm and the Urban Environment

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors

Stimulation of glucose transport by thyroid hormone in ARL 15 cells : increased abundance of glucose transporter protein and messenger ribonucleic acid

Tissue distribution of the human GLUT3 glucose transporter

Regulation of GLUT2 glucose transporter expression in liver by thyroid hormone : evidence for hormonal regulation of the hepatic glucose transport system

Tobacco Smoking: Current Concepts in Etiology and Treatment

Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle

Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle

Suchergebnisse filtern